Habeo Cell Therapy (ECCS-50) - Plus Therap
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis (clinicaltrials.gov) - Dec 24, 2019 - P1; N=25; Recruiting; Sponsor: Mayo Clinic; Trial completion date: Jun 2022 ➔ Dec 2023; Trial primary completion date: Jun 2020 ➔ Dec 2021 
Clinical • Trial completion date • Trial primary completion date • MRI
http://clinicaltrials.gov/ct2/show/NCT03269409
 
Dec 24, 2019
 
Prev Next